| Literature DB >> 30564267 |
John Paul Spence1, Jill L Reiter1, Bin Qiu2, Hao Gu2, Dawn K Garcia3, Lingling Zhang2, Tamara Graves1, Kent E Williams1, Paula J Bice4, Yi Zou3, Zhao Lai4, Weidong Yong2, Tiebing Liang1.
Abstract
Humans show sex differences related to alcohol use disorders (AUD). Animal model research has the potential to provide important insight into how sex differences affect alcohol consumption, particularly because female animals frequently drink more than males. In previous work, inbred strains of the selectively bred alcohol-preferring (P) and non-preferring (NP) rat lines revealed a highly significant quantitative trait locus (QTL) on rat chromosome 4, with a logarithm of the odds score of 9.2 for alcohol consumption. Recently, interval-specific congenic strains (ISCS) were developed by backcrossing the congenic P.NP line to inbred P (iP) rats to further refine the chromosome 4 QTL region. Two ISCS sub-strains, ISCS-A and ISCS-B, were obtained with a narrowed QTL, where the smallest region of overlap consisted of 8.9 Mb in ISCS-B. Interestingly, we found that females from both ISCS lines consumed significantly less alcohol than female iP controls (p < 0.05), while no differences in alcohol consumption were observed between male ISCS and iP controls. RNA-sequencing was performed on the nucleus accumbens of alcohol-naïve female ISCS-B and iP rats, which revealed differentially expressed genes (DEG) with greater than 2-fold change and that were functionally relevant to behavior. These DEGs included down-regulation of Oxt, Asb4, Gabre, Gabrq, Chat, Slc5a7, Slc18a8, Slc10a4, and Ngfr, and up-regulation of Ttr, Msln, Mpzl2, Wnt6, Slc17a7, Aldh1a2, and Gstm2. Pathway analysis identified significant alterations in gene networks controlling nervous system development and function, as well as cell signaling, GABA and serotonin receptor signaling and G-protein coupled receptor signaling. In addition, β-estradiol was identified as the most significant upstream regulator. The expression levels of estrogen-responsive genes that mapped to the QTL interval and have been previously associated with alcohol consumption were measured using RT-qPCR. We found that expression of the Adcyap1r1 gene, encoding the pituitary adenylate cyclase-activating polypeptide type 1 (PAC1) receptor, was upregulated in female ISCS-B compared to female iP controls, while no differences were exhibited in males. In addition, sequence variants in the Adcyap1r1 promoter region showed a differential response to estrogen stimulation in vitro. These findings demonstrate that rat chromosome 4 QTL contains genetic variants that respond to estrogen and are associated with female alcohol consumption.Entities:
Keywords: Adcyap1r1; RNA-seq; alcohol use disorder; congenic rat model; nucleus accumbens; sex-difference
Year: 2018 PMID: 30564267 PMCID: PMC6288178 DOI: 10.3389/fgene.2018.00513
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
FIGURE 1P.NP is the congenic strain with the Chr4 QTL region in P rats replaced by the NP Chr4. Backcrossing P.NP with iP rat resulted in interval-specific congenic strains (ISCS). ISCS-A and ISCS-B shared a narrowed Chr4 QTL between 83.8 and 92.7 Mb (region in dash-lined box). Relative to iP control rats, only females in either ISCS consumed less alcohol; alcohol consumption (gEtOH/Kg/day) was calculated and is shown as mean ± SEM. ∗indicates p < 0.05.
Top 30 up- and down-regulated genes.
| Gene symbol | Full name | log2 fold change | adj- |
|---|---|---|---|
| Oxytocin/neurophysin 1 prepropeptide | -8.582 | 0.019 | |
| Transmembrane protein 212 | -4.604 | 0.003 | |
| Gamma-aminobutyric acid (GABA) A receptor; epsilon | -3.494 | 0.017 | |
| Nerve growth factor receptor | -3.321 | 0.000 | |
| Spermatogenesis associated 18 | -3.043 | 0.009 | |
| microRNA 384 | -2.644 | 0.007 | |
| LIM homeobox 8 | -2.427 | 0.000 | |
| WD repeat domain 63 | -2.308 | 0.045 | |
| Solute carrier family 18 member A3 | -2.164 | 0.000 | |
| Solute carrier family 5 (sodium/choline cotransporter); member 7 | -2.087 | 0.000 | |
| Estrogen receptor 1 | -2.064 | 0.013 | |
| Choline O-acetyltransferase | -2.004 | 0.000 | |
| Solute carrier family 10; member 4 | -1.997 | 0.000 | |
| Kelch-like family member 1 | -1.989 | 0.003 | |
| ST8 alpha-N-acetyl-neuraminidase alpha-2;8-sialyltransferase 6 | -1.964 | 0.008 | |
| Neurotrophic tyrosine kinase; receptor; type 1 | -1.962 | 0.000 | |
| G protein-coupled receptor 165 | -1.900 | 0.001 | |
| Zinc finger; imprinted 1 | -1.853 | 0.000 | |
| Serine/threonine kinase 32B | -1.835 | 0.000 | |
| Endothelin converting enzyme-like 1 | -1.733 | 0.000 | |
| Dynein light chain roadblock-type 2 | -1.722 | 0.031 | |
| Neurotensin receptor 1 | -1.713 | 0.000 | |
| Gastrulation brain homeobox 1 | -1.708 | 0.000 | |
| Protein phosphatase 1; regulatory subunit 32 | -1.682 | 0.000 | |
| Parathyroid hormone 2 receptor | -1.661 | 0.000 | |
| Sonic hedgehog | -1.625 | 0.000 | |
| Solute carrier family 27 (fatty acid transporter); member 2 | -1.624 | 0.002 | |
| Leucine rich repeat containing 34 | -1.624 | 0.001 | |
| NK2 homeobox 1 | -1.617 | 0.001 | |
| Glutathione peroxidase 3 | -1.608 | 0.014 | |
| 5.8S ribosomal RNA | 2.898 | 0.019 | |
| hypothetical protein LOC310926 | 2.247 | 0.001 | |
| myelin protein zero-like 2 | 1.945 | 0.000 | |
| beta globin minor gene | 1.923 | 0.037 | |
| beta-globin | 1.849 | 0.014 | |
| shisa family member 3 | 1.797 | 0.001 | |
| chemokine (C-C motif) ligand 9 | 1.783 | 0.025 | |
| aquaporin 1 | 1.744 | 0.000 | |
| chemokine (C-X-C motif) ligand 10 | 1.698 | 0.034 | |
| wingless-type MMTV integration site family; member 6 | 1.663 | 0.000 | |
| glutathione S-transferase mu 2 | 1.637 | 0.011 | |
| odd-skipped related transciption factor 1 | 1.550 | 0.000 | |
| RT1 class II; locus Da | 1.545 | 0.000 | |
| Cd74 molecule; major histocompatibility complex; class II invariant chain | 1.544 | 0.000 | |
| folate receptor 2 (fetal) | 1.541 | 0.024 | |
| cadherin 1 | 1.540 | 0.023 | |
| potassium channel; inwardly rectifying subfamily J; member 13 | 1.503 | 0.000 | |
| gap junction protein; beta 2 | 1.494 | 0.000 | |
| transcription factor AP-2 beta | 1.489 | 0.004 | |
| prostaglandin D2 synthase (brain) | 1.463 | 0.000 | |
| similar to RIKEN cDNA 1500015O10 | 1.457 | 0.002 | |
| C-type lectin domain family 10; member A | 1.451 | 0.000 | |
| cytochrome P450; family 1; subfamily b; polypeptide 1 | 1.449 | 0.010 | |
| procollagen C-endopeptidase enhancer 2 | 1.447 | 0.000 | |
| basic helix-loop-helix family; member e22 | 1.440 | 0.000 | |
| solute carrier family 22 (organic anion transporter); member 6 | 1.438 | 0.000 | |
| relaxin 1 | 1.423 | 0.006 | |
| serpin peptidase inhibitor; clade F (alpha-2 antiplasmin; pigment epithelium derived factor); member 1 | 1.402 | 0.001 | |
| schlafen 3 | 1.394 | 0.000 | |
| cholinergic receptor; nicotinic; beta 3 (neuronal) | 1.363 | 0.002 | |
FIGURE 2A total of 73 differentially expressed genes (DEG) between female iP and ISCS-B rats possess a fold change >2 with p < 0.05. The significance of these genes was plotted by corresponding chromosomes. Genes with the lowest p-values for each chromosome are labeled.
FIGURE 3In depth analysis of DEG between ISCS-B and iP using IPA. The most significant IPA canonical pathways are listed on the left. The stacked bar chart reveals the percentage of up-regulated (red) and down-regulated (green) genes within each canonical pathway. The numerical value at the right of each bar represents the total number of genes in the canonical pathways. The secondary x-axis (bottom) represents the -log of p-value.
Upstream regulators.
| Upstream regulator | Full name | Activation | |
|---|---|---|---|
| Beta-estradiol | Beta-estradiol | -0.563 | 1.78E-23 |
| SNCA | α-synuclein | 3.667 | 2.27E-12 |
| CTNNB1 | Catenin beta 1 | 0.807 | 1.47E-11 |
| Progesterone | Progesterone | 1.34 | 2.95E-11 |
| HTT | Huntingtin | 0.808 | 7.94E-11 |
| CREB1 | cAMP responsive element binding protein 1 | 0.952 | 1.03E-10 |
| JAK1/2 | Janus kinase 1 | 4.123 | 1.74E-10 |
| BDNF | Brain derived neurotrophic factor | -1.374 | 8.24E-10 |
| JUN | Jun proto-oncogene, AP-1 transcription factor subunit | 1.345 | 1.57E-09 |
| IFNG | Interferon gamma | 2.602 | 8.33E-09 |
| Dihydrotestosterone | Dihydrotestosterone | 0.89 | 2.37E-08 |
| ESR1 | Estrogen receptor 1 | -0.193 | 3.36E-08 |
FIGURE 4Reactome database was used to analyze DEG relationships organized into biological pathways and processes (https://reactome.org/dev/). It reveals significant alterations in signal transduction pathways between female iP and ISCS-B rats. Color-highlighted edges indicate over-represented interactions.
FIGURE 5RT-qPCR comparisons of gene expression between male and female iP and ISCS-B rats. Chat, Slc18a3, Lhx8, and Ngfr were confirmed to be differentially expressed in both male and female ISCS-B compared to iP rats. Adcyap1r1 and Nap1L5 were upregulated in female ISCS-B compared to iP animals, but no difference was found in males.
FIGURE 6(A) Adcyap1r1 expression is increased in female ISCS-B relative to iP rats. (B) Male ISCS-B rats demonstrate no significant difference from iP in Adcyap1r1 expression. (C) A schematic of the Adcyap1r1 promoter sequence demonstrating ER binding sites and polymorphisms between iP and iNP. (D) ERα transactivation of both variants of the Adcyap1r1 promoter enhanced luciferase activity, but the iNP promoter exhibited significantly more luciferase activity than iP.
Promoter variance in Adcyap1r1 gene.
| 304–314 repeat C | 524 | 532–533 | 1283 | 1885–1886 | |
|---|---|---|---|---|---|
| ReqSeq | C (11) | G | - | T | - |
| iP | C (10) | CGT | - | - | A |
| iNP | C (13) | G | C insertion | T | G |
FIGURE 7DEGs were enriched in two pathways which affect neuron function and are also regulated by estrogen receptor (ER). Adenylate cyclase (AC) and downstream signaling affecting neuroprotection was upregulated, while NtrK, Ngfr, and Lhx8 signaling affecting apoptosis were downregulated.
FIGURE 8Schematic of genetic and estrogen receptor interaction affecting gene expression. The only difference between congenic P.NP and iP is on Chr4 region. Compared with P genomic sequence, the genetic difference in NP is proposed to lead to stronger binding of estrogen receptor in promoters of targeted genes resulting in increased gene expression.